|
器官移植中霉酚酸的药代动力学 |
| |
n Pharmacokinet 1998; 34: 429-55
2. Shipkova M, Strassburg CP, Braun F, et al. Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol 2001; 132: 1027-34
3. Shipkava M, Wieland E, Schutz E, et al. The acyl glucuronide metabolite of mycophenolic acid inhitbits the proliferation of human mononuclear leukocytes. Transplant Proc 2001; 33: 1080-1
4. Schütz E, Shipkova M, Armstrong VW, et al. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Clin Chem 1999; 45: 419-22
5. Shipkova M, Armstrong VW, Oellerich M, et al. Acyl glucuronide durg metabolites: toxicological and analytical implications. Ther Drug Monit 2003; 25: 1-16
6. Kobayashi M, Saitoh H. Cyclosporin A, but not Tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats. J Pharmacol Exp Ther 2004; 309: 1029-35
7. Roberts MS, Magnusson BM. Enterohepatic circulation：physiological，pharmacokinetic and clinical implications．Clin Pharmacokinet 2002; 41: 751-90
8. Shaw LM, Nawrocki A. Using Established Immunosuppressant Therapy Effectively: Lessons from the Measurement of Mycophenolic Acid Plasma Concentrations. Ther Drug Monit 2004; 26: 347-51
9. Nowak I, Shaw LM. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin Chem 1995; 41: 1011-7
10. Weber LT, Shipkova M, Armstrong VW. The pharmacokinetic- pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mof << 上一页 [11] [12] [13] 下一页
上一个医学论文： 术前呼吸功能训练预防腹部手术后肺部并发症的体会
下一个医学论文： 36例粘膜原发恶性黑色素瘤临床病理分析及鉴别诊断
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 儿科论文 >> 正文